Hemophilia A Treatment Study

Clinical Trial Title

Prospective, open-label multicenter phase 3b to assess the efficacy and safety of personalized prophylaxis with Human-cl rh-FVIII in previously treated adult with severe hemophilia A.

Clinical Trial Protocol Description:

Prophylaxis infusion with PK studies.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Have severe hemophilia A.
  • Are male and at least 18 years of age.

This is a partial list of elgibility requirements.

Study Details

Clinical Trial Investigator

Lisa Boggio, MD

Contact Information

Lisa Boggio, MD

(312) 942-3034